Erasca 配当金
配当金 基準チェック /06
Erasca does not have a record of paying a dividend.
主要情報
n/a
配当利回り
-28.5%
バイバック利回り
総株主利回り | -28.5% |
将来の配当利回り | 0% |
配当成長 | n/a |
次回配当支払日 | n/a |
配当落ち日 | n/a |
一株当たり配当金 | n/a |
配当性向 | n/a |
最近の配当金アップデート
更新なし
Recent updates
We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth
Oct 15Erasca: New Focus After Restructuring, But Need More Differentiation
Sep 30Is Erasca (NASDAQ:ERAS) In A Good Position To Deliver On Growth Plans?
Feb 21We Think Erasca (NASDAQ:ERAS) Needs To Drive Business Growth Carefully
Nov 16Companies Like Erasca (NASDAQ:ERAS) Are In A Position To Invest In Growth
Jun 28We Think Erasca (NASDAQ:ERAS) Can Afford To Drive Business Growth
Jan 20Erasca forms clinical trial partnership with Pfizer for cancer therapy
Oct 20Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation
Sep 23Erasca adds 10% ahead of R&D Day
Sep 07Erasca, Eli Lilly to collaborate on trial to evaluate combo treatment for two cancers
Jul 18We're Not Very Worried About Erasca's (NASDAQ:ERAS) Cash Burn Rate
Apr 12Here's Why We're Not Too Worried About Erasca's (NASDAQ:ERAS) Cash Burn Situation
Dec 28決済の安定と成長
配当データの取得
安定した配当: Insufficient data to determine if ERAS's dividends per share have been stable in the past.
増加する配当: Insufficient data to determine if ERAS's dividend payments have been increasing.
配当利回り対市場
Erasca 配当利回り対市場 |
---|
セグメント | 配当利回り |
---|---|
会社 (ERAS) | n/a |
市場下位25% (US) | 1.5% |
市場トップ25% (US) | 4.5% |
業界平均 (Biotechs) | 2.2% |
アナリスト予想 (ERAS) (最長3年) | 0% |
注目すべき配当: Unable to evaluate ERAS's dividend yield against the bottom 25% of dividend payers, as the company has not reported any recent payouts.
高配当: Unable to evaluate ERAS's dividend yield against the top 25% of dividend payers, as the company has not reported any recent payouts.
株主への利益配当
収益カバレッジ: Insufficient data to calculate ERAS's payout ratio to determine if its dividend payments are covered by earnings.
株主配当金
キャッシュフローカバレッジ: Unable to calculate sustainability of dividends as ERAS has not reported any payouts.